Cathie Wood's position in Palantir is spread across five different funds: ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Fintech Innovation ETF, ARK Next Generation Internet ETF, and ARK Space Exploration & Innovation ETF.

Cathie Wood’s Ark Invest sold shares of Palantir Technologies on Tuesday, a trade worth $41.03 million, according to Benzinga. Palantir’s stock declined after its latest earnings report, despite beating analyst expectations,

Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of about $1.19 million. The consistent buying pattern in CRISPR Therapeutics over the past week underscores ARK’s bullish stance on the biotech sector.